Daniel Galun

1.0k total citations
8 papers, 100 citations indexed

About

Daniel Galun is a scholar working on Molecular Biology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Daniel Galun has authored 8 papers receiving a total of 100 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Daniel Galun's work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Plant tissue culture and regeneration (2 papers) and Toxin Mechanisms and Immunotoxins (2 papers). Daniel Galun is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Plant tissue culture and regeneration (2 papers) and Toxin Mechanisms and Immunotoxins (2 papers). Daniel Galun collaborates with scholars based in Serbia, Germany and Netherlands. Daniel Galun's co-authors include Tatjana Srdić‐Rajić, Zlatibor Lončar, Marinko Žuvela, Harald Matthes, Anja Thronicke, Gil Bar‐Sela, Friedemann Schad, Roman Huber, Ralf‐Dieter Hofheinz and David Martín and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Daniel Galun

7 papers receiving 98 citations

Peers

Countries citing papers authored by Daniel Galun

Since Specialization

Citations

This map shows the geographic impact of Daniel Galun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Galun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Galun more than expected).

Fields of papers citing papers by Daniel Galun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Galun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Galun. The network helps show where Daniel Galun may publish in the future.

Co-authorship network of co-authors of Daniel Galun

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Galun. A scholar is included among the top collaborators of Daniel Galun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Galun. Daniel Galun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	P-073 THE MODIFIED SUBLAY TECHNIQUE FOR THE MANAGEMENT OF MAJOR SUBCOSTAL INCISIONAL HERNIA: LONG-TERM FOLLOW-UP RESULTS OF 41 CONSECUTIVE PATIENTS 2022 ·British journal of surgery ·(unknown), Daniel Galun, (unknown), (unknown), M Zivanovic, (unknown), (unknown)	0
2	The role of quantitative diffusion-weighted imaging in characterization of hypovascular liver lesions: A prospective comparison of intravoxel incoherent motion derived parameters and apparent diffusion coefficient 2021 ·PLoS ONE ·Jelena Djokić Kovač, Marko Daković, Aleksandra Janković, (unknown), (unknown), Daniel Galun, Aleksandra Djurić-Stefanović, Dragan Mašulović	6
3	Statement to an Insufficient Systematic Review on Viscum album L. Therapy 2020 ·Evidence-based Complementary and Alternative Medicine ·Harald Matthes, Anja Thronicke, Ralf‐Dieter Hofheinz, Erik W. Baars, David Martín, Roman Huber, (unknown), Gil Bar‐Sela, Daniel Galun, Friedemann Schad	18
4	Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies 2017 ·SHILAP Revista de lepidopterología ·Daniel Galun, Tatjana Srdić‐Rajić, (unknown), Zlatibor Lončar, Marinko Žuvela	53
5	Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells 2017 ·Scientific Reports ·Tatjana Srdić‐Rajić, Juan F. Santibáñez, Ksenija Kanjer, (unknown), Milena Čavić, Daniel Galun, M. Jevric, Nevena Kardum, Aleksandra Konić‐Ristić, Tamara Zoranovic	14
6	Treatment of a Patient with Abdominal Aortic Aneurysm and Hepatocellular Carcinoma 2016 ·Annals of Vascular Surgery ·Slobodan Cvetković, Igor Končar, Daniel Galun, (unknown), Miroslav Marković, Nikola Ilić, Marko Dragaš, Lazar Davidović	2
7	Mistletoe Extract Therapy versus No Antineoplastic Therapy in Patients with Locally advanced or Metastatic Pancreatic Cancer: a Randomized Clinical Phase III Trial on Overall Survival 2012 ·Annals of Oncology ·Daniel Galun, Wilfried Tröger, Marcus Reif, (unknown), Nikola Stanković, (unknown)	3
8	Radioimmunoscintigraphy of colorectal carcinomas with 99mTc-labelled antibodies. 2011 ·PubMed ·(unknown), Miloš Petrović, Dragana Šobić-Šaranović, (unknown), (unknown), (unknown), (unknown), Mirjana Stojković, (unknown), Marinko Žuvela, (unknown), Daniel Galun, Zorica Petrasinovic, S. Pavlović, Zoran Krivokapić, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact